Glaukos
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Glaukos and other ETFs, options, and stocks.About GKOS
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology.
GKOS Key Statistics
Stock Snapshot
The current Glaukos(GKOS) stock price is $108.27, with a market capitalization of 6.29B. The stock trades at a price-to-earnings (P/E) ratio of -34.27.
During the trading session on 2026-03-06, Glaukos(GKOS) shares reached a daily high of $109.45 and a low of $106.50. At a current price of $108.27, the stock is +1.7% higher than the low and still -1.1% under the high.
Trading volume for Glaukos(GKOS) stock has reached 466.34K, versus its average volume of 651.19K.
The stock's 52-week range extends from a low of $73.16 to a high of $130.23.
The stock's 52-week range extends from a low of $73.16 to a high of $130.23.
GKOS News
In February 2026, Glaukos Corporation reported past fourth-quarter and full-year 2025 results showing sales rising to US$143.12 million for the quarter and US$5...
Glaukos ( (GKOS) ) has issued an update. Glaukos Corporation released an investor presentation in March 2026 outlining its strategy to transform glaucoma and k...
Analyst ratings
88%
of 16 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.